Cargando…

Q&A: targeting autophagy in cancer—a new therapeutic?

Macroautophagy (autophagy hereafter) captures and degrades intracellular proteins and organelles in lysosomes as a quality control mechanism and recycles their components to sustain survival in starvation. Cellular self-cannibalization by autophagy is thought to have a context-dependent role in canc...

Descripción completa

Detalles Bibliográficos
Autor principal: White, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160717/
https://www.ncbi.nlm.nih.gov/pubmed/25215185
http://dx.doi.org/10.1186/2049-3002-2-14
_version_ 1782334447042953216
author White, Eileen
author_facet White, Eileen
author_sort White, Eileen
collection PubMed
description Macroautophagy (autophagy hereafter) captures and degrades intracellular proteins and organelles in lysosomes as a quality control mechanism and recycles their components to sustain survival in starvation. Cellular self-cannibalization by autophagy is thought to have a context-dependent role in cancer. Autophagy inactivation is destructive to normal tissues and can promote cancer initiation while some established cancers upregulate autophagy that promotes their survival. We are only beginning to understand the role of autophagy in cancer and the precise mechanisms behind tumour suppression and promotion and the molecular and physiological contexts involved.
format Online
Article
Text
id pubmed-4160717
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41607172014-09-12 Q&A: targeting autophagy in cancer—a new therapeutic? White, Eileen Cancer Metab Opinion Macroautophagy (autophagy hereafter) captures and degrades intracellular proteins and organelles in lysosomes as a quality control mechanism and recycles their components to sustain survival in starvation. Cellular self-cannibalization by autophagy is thought to have a context-dependent role in cancer. Autophagy inactivation is destructive to normal tissues and can promote cancer initiation while some established cancers upregulate autophagy that promotes their survival. We are only beginning to understand the role of autophagy in cancer and the precise mechanisms behind tumour suppression and promotion and the molecular and physiological contexts involved. BioMed Central 2014-09-11 /pmc/articles/PMC4160717/ /pubmed/25215185 http://dx.doi.org/10.1186/2049-3002-2-14 Text en Copyright © 2014 White; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
White, Eileen
Q&A: targeting autophagy in cancer—a new therapeutic?
title Q&A: targeting autophagy in cancer—a new therapeutic?
title_full Q&A: targeting autophagy in cancer—a new therapeutic?
title_fullStr Q&A: targeting autophagy in cancer—a new therapeutic?
title_full_unstemmed Q&A: targeting autophagy in cancer—a new therapeutic?
title_short Q&A: targeting autophagy in cancer—a new therapeutic?
title_sort q&a: targeting autophagy in cancer—a new therapeutic?
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160717/
https://www.ncbi.nlm.nih.gov/pubmed/25215185
http://dx.doi.org/10.1186/2049-3002-2-14
work_keys_str_mv AT whiteeileen qatargetingautophagyincanceranewtherapeutic